| Literature DB >> 24348190 |
Chih-Hong Lee1, Chin-Song Lu2, Wen-Li Chuang2, Tu-Hsueh Yeh2, Shih-Ming Jung3, Chia-Ling Huang4, Szu-Chia Lai2.
Abstract
OBJECTIVES: Pantothenate kinase-associated neurodegeneration (PKAN) is a rare disease caused by pantothenate kinase 2 (PANK2, OMIM 606157) mutations. This study is aimed to investigate clinical presentations, pathologies, and genetics in patients with PKAN.Entities:
Mesh:
Substances:
Year: 2013 PMID: 24348190 PMCID: PMC3854131 DOI: 10.1155/2013/860539
Source DB: PubMed Journal: ScientificWorldJournal ISSN: 1537-744X
Figure 1(a) The iron stain of the brain of our patient one showed diffuse granules with iron deposits in the globus pallidus. (b) Sequence chromatographs of exon 3 of PANK2 gene showed a heterozygous T insertion (c.1408insT) leading to a stop codon and therefore a truncation of the protein at position 350 (I349X).
Figure 2(a) Surface electromyography recording on a distal part of the arm at rest showed alternating rhythmic bursts at a frequency of 5-6 Hz. (b) Surface electromyography recording on a proximal part of the arm during outstretching showed short-duration, large amplitude arrhythmic bursts, mostly due to synchronous activities.
Clinical features and genetic mutations in Asian patients with PKAN.
| Patient | Category | Onset | Cognitive | Bulbar | Gait | Dystonia | Tremor | Parkinsonism | Chorea | Pyramidal signs | Eye-of-the-tiger on MRI |
| Reference |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Atypical | 23/M | N | D | Y | S; C | Y | Y | N | N | Y | Unknown | Our patient 1 |
| 2 | Atypical | 17/M | N | N | N | S; C | Y | N | N | N | Y | I349X | Our patient 2 |
| 3 | Atypical | 46/M | Y | D | Y | S; C | Y | N | N | N | Y | D378G/D452G | Wu et al. [ |
| 4 | Atypical | 51/M | N | N | Y | S; C | Y | Y | N | N | N | D378G/D452G | Wu et al. [ |
| 5 | Atypical | 17/M | N | D | N | S; C | Y | Y | N | N | Y | D378G/I501N | Zhang et al. [ |
| 6 | Atypical | 35/M | N | D | Y | C | Y | Y | N | N | Y | D378G/ R440P L385fsX11 | Seo et al. [ |
| 7 | Atypical | 48/M | N | N | N | N | Y | N | N | N | Y | L385fsX11/R440P | Yoon et al. [ |
| 8 | Atypical | 21/M | N | N | N | S | N | N | N | N | Y | K335E | Chung et al. [ |
| 9 | Atypical | 29/M | N | N | Y | S | Y | N | N | Y | Y | D378G, L425del | Lyoo et al. [ |
| 10 | Atypical | 28/M | N | D; d | N | N | Y | Y | N | N | Y | I346S | Doi et al. [ |
| 11 | Atypical | 35/F | N | N | N | S | N | N | Y | N | Y | I346S | Doi et al. [ |
| 12 | Atypical | 18/F | N | N | Y | N | Y | N | N | Y | Y | N355S | Yamashita et al. [ |
| 13 | Classic | 9/F | Y | N | Y | N | N | Y | N | Y | Y | Unknown |
Saito et al. [ |
| 14 | Classic | 8/M | Y | D | Y | C | N | N | Y | N | N | Unknown |
Saito et al. [ |
| 15 | Classic | 4/M | N | D; d | Y | G | N | N | Y | N | Y | Unknown | Koyama and Yagishita [ |
| 16 | Classic | 9/M | Y | D | Y | N | N | N | N | Y | N | Unknown |
Wakabajashi et al. [ |
| 17 | Classic | 6/M | N | D; d | N | G | N | N | N | Y | Y | Unknown | Tsukamoto et al. [ |
| 18 | Classic | 2/M | N | D; d | Y | G | Y | N | Y | Y | Y | Unknown | Ou et al. [ |
| 19 | Classic | 10/M | N | D | Y | G; C | N | N | Y | N | Y | P464L | Chan et al. [ |
| 20 | Classic | 2.5/F | N | D; d | Y | G | Y | N | N | N | Y | Unknown | Chan et al. [ |
| 21 | Classic | 10/M | Y | D; d | Y | G | N | N | N | Y | Y | Unknown |
Fung and Chan [ |
PKAN: pantothenate kinsase-associated neurodegeneration; M: male; F: female; Y: yes; N: no; D: dysarthria; d: dysphagia; G: generalized; S: segmental; C: cranial.
Clinical findings in Asian patients: classic versus atypical.
| Classic | Atypical |
| |
|---|---|---|---|
|
|
| ||
| Age at onset (years) | 6.7 (2–10) | 30.7 (17–51) | <0.05 |
| Dysarthria | 89% | 42% | |
| Gait disturbance | 89% | 50% | |
| Dystonia | 78% | 75% | |
| General dystonia | 67% | 0% | <0.05 |
| Cranial dystonia | 22% | 50% | |
| Segmental dystonia | 0% | 67% | <0.05 |
| Dysphagia | 56% | 8% | <0.05 |
| Pyramidal signs | 56% | 17% | |
| Mental impairment | 44% | 8% | |
| Limb chorea | 44% | 8% | |
| Tremors | 22% | 83% | <0.05 |
| Parkinsonism | 11% | 42% | |
| Psychiatric symptoms | 0% | 0% |
*Blank indicates it does not reach statistical significance (P ≥ 0.05).
Clinical findings in patients with PKAN: Asians versus Caucasians.
| Classic patients | Atypical patients | |||
|---|---|---|---|---|
| Asians | Caucasians | Asians | Caucasians | |
|
|
|
|
| |
| Age at onset (years) | 6.7 (2–10) | 4.7 (1–10) | 30.7 (17–51) | 18.3 (11–30) |
| Dysarthria | 89%* | 50% | 42% | 44% |
| Dystonia | 78% | 93% | 75% | 94% |
| General dystonia | 67% | 87% | 0%* | 89% |
| Cranial dystonia | 22%* | 81% | 50%* | 89% |
| Segmental dystonia | 0% | 4% | 67%* | 6% |
| Pyramidal signs | 56%* | 89% | 17%* | 83% |
| Mental impairment | 44%* | 85% | 8%* | 72% |
| Parkinsonism | 11%* | 50% | 42% | 39% |
| Psychiatric symptoms | 0% | 6% | 0% | 22% |
*Indicates the difference between Asians and Caucasians in each group (classic or atypical) reaches scientific significance, that is, P < 0.05.
Figure 3Common mutations of PANK2 gene in Asians and Caucasians.